FindTrial
Sign In

A medical records based study for observation of Teriparatidec in the treatment of congenital hypoparathyroidism

The observation of Teriparatide in the treatment of congenital hypoparathyroidism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047758
Enrollment
Unknown
Registered
2021-06-26
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Hypoparathyroidism

Interventions

Teriparatide group:No
Control group:No

Sponsors

The Seventh Medical Center, PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6 months to 18 years; 2. Reduced parathyroid hormone; 3. There are calcified lesions in the skull.

Exclusion criteria

Exclusion criteria: 1. Temporary hypoparathyroidism; 2. Liver or kidney disease; 3. Abnormal thyroid function.

Design outcomes

Primary

MeasureTime frame
Blood parathyroid hormone concentration;—

Countries

China

Contacts

Public ContactWang Sanmei

The Seventh Medical Center, PLA General Hospital

wangsanmei66@163.com+86 13683383295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026